This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Oct;10(10):871; author reply 871-2.

doi: 10.1016/S1474-4422(11)70189-2.

Clazosentan for patients with subarachnoid haemorrhage: lessons learned

George Kwok Chu Wong, Wai Sang Poon

PMID: 21939894
DOI: 10.1016/S1474-4422(11)70189-2

Comment

Clazosentan for patients with subarachnoid haemorrhage: lessons learned

George Kwok Chu Wong et al. Lancet Neurol. 2011 Oct.

. 2011 Oct;10(10):871; author reply 871-2.

doi: 10.1016/S1474-4422(11)70189-2.

Authors

George Kwok Chu Wong, Wai Sang Poon

PMID: 21939894
DOI: 10.1016/S1474-4422(11)70189-2

No abstract available

PubMed Disclaimer

Comment on

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).
Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N. Macdonald RL, et al. Lancet Neurol. 2011 Jul;10(7):618-25. doi: 10.1016/S1474-4422(11)70108-9. Epub 2011 Jun 2. Lancet Neurol. 2011. PMID: 21640651 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science